logo
Twitter
Discord
Email
logo
The Ensign Group, Inc.

The Ensign Group, Inc.

NASDAQ•ENSG
CEO: Mr. Christopher R. Christensen
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2007-11-09
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Contact Information
29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA, 92675, United States
949-487-9500
ensigngroup.net
Market Cap
$10.23B
P/E (TTM)
30.9
34.2
Dividend Yield
0.1%
52W High
$194.00
52W Low
$118.73
52W Range
79%
Rank25Top 11.9%
5.6
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$1.30B+19.84%
4-Quarter Trend

EPS

$1.46+5.80%
4-Quarter Trend

FCF

$101.81M+14.34%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Grew 18.2% Total revenue reached $3.70B USD for nine months ended September 30, 2025, marking an 18.2% increase over prior year period.
Net Income Increased Substantially Net income attributable to ENSG grew to $248.5M USD for nine months, up from $218.3M USD in the comparable prior period.
Operating Cash Flow Strong Cash provided by operating activities totaled $381.0M USD for nine months, a $134.2M USD increase year-over-year.
Skilled Services Revenue Up Skilled services revenue increased 18.1% to $3.54B USD for nine months, driven by occupancy gains and higher daily rates.

Risk Factors

Regulatory Environment Uncertainty Anticipated political environment changes and new legislation like OBBB may significantly alter reimbursement framework and increase compliance costs.
Increased Litigation Exposure Ongoing DOJ investigation and adverse jury verdict in Arizona trial increase legal costs and potential financial impact on operations.
Labor Costs and Staffing Shortages Competition for skilled personnel drives higher labor costs, potentially leading to monetary fines for failure to meet state staffing requirements.
Reimbursement Rate Volatility Medicare/Medicaid reimbursement rates are subject to frequent statutory changes, potentially causing substantial reductions in revenue and operating margins.

Outlook

Continued Strategic Expansion Expanded operations by 34 new facilities in nine months; strategy focuses on accretive acquisitions consistent with geographic objectives.
REIT Qualification Maintained Standard Bearer REIT structure remains in conformity with requirements; monitoring legislative actions affecting REIT tax treatment going forward.
Monitoring Regulatory Compliance Actively evaluating impact of new CMS rules, including ownership transparency and staffing methodology changes, to ensure compliance.
Capital Resources Sufficient Current cash, investments, and Credit Facility availability support operating needs for at least the next 12 months forecast period.

Peer Comparison

Revenue (TTM)

Molina Healthcare, Inc.MOH
$44.55B
+13.7%
Universal Health Services, Inc.UHS
$16.99B
+10.2%
DaVita Inc.DVA
$13.32B
+5.1%

Gross Margin (Latest Quarter)

Universal Health Services, Inc.UHS
90.8%
+0.6pp
BioMarin Pharmaceutical Inc.BMRN
82.0%
+7.2pp
Align Technology, Inc.ALGN
64.2%
-5.5pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
RVTY$13.07B51.33.2%27.8%
UHS$13.01B9.619.9%33.3%
ALGN$12.21B32.99.8%1.9%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
4.6%
Moderate Growth
4Q Net Income CAGR
1.7%
Profitability Slowly Improving
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Feb 4, 2026
|
EPS:$1.75
|
Revenue:-
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 3, 2025|
    Revenue: $1.30B+19.8%
    |
    EPS: $1.46+5.8%
    Miss
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 24, 2025|
    Revenue: $1.23B+18.5%
    |
    EPS: $1.48+17.5%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 29, 2025|
    Revenue: $1.17B+16.1%
    |
    EPS: $1.41+15.6%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 5, 2025|
    Revenue: $4.26B+14.2%
    |
    EPS: $5.26+39.9%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 24, 2024|
    Revenue: $1.08B+15.0%
    |
    EPS: $1.38+21.1%
    Meet
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Jul 25, 2024|
    Revenue: $1.04B+12.5%
    |
    EPS: $1.26+9.6%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 1, 2024|
    Revenue: $1.01B+13.9%
    |
    EPS: $1.22+13.0%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 1, 2024|
    Revenue: $3.73B+23.3%
    |
    EPS: $3.76-8.1%
    Beat